A conversation co-hosted by Tradeoffs and Penn LDI examines how arbitration rules are inflating payments and overwhelming the system.
Health Care Policies
How a Supreme Court Fight Over Fish Oil Could Raise Your Prescription Drug Costs
The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.
One State’s Sprint for its Share of $50 Billion for Rural Health: Part 2
Maryland finds out how much the state will get from a nationwide competition for federal rural health investment.
Inside Maryland’s High-Stakes Bid for Trump’s $50 Billion Rural Health Fund
The White House asked states to compete for a rare pot of new money dedicated to transforming health care across rural America.
Letter from the Editor: A Consequential Year
A message from Tradeoffs founder and executive editor Dan Gorenstein.
Watch: The $50 Billion Rural Health Program in Context
Experts discuss what the new federal approach means for access, outcomes, and financial stability in rural America.
What Would Actually Lower Drug Prices in America? Experts Weigh In
Some of America’s top scholars on prescription drug pricing outline steps the Trump administration could take to make medicines more affordable.
A Closer Look at a Widely Despised Health Insurance Policy
Every year, millions of people’s medical care runs into the roadblock known as prior authorization, which requires a patient’s health insurer to sign off before chemotherapy, surgery or countless other services can proceed. Who does this often onerous process help, who does it hurt and how could it work better for everyone?
Former North Carolina Health Secretary Sees Hard Road Ahead for States
Sweeping federal reforms force North Carolina and other states to make tough decisions about Medicaid coverage, costs and eligibility under mounting budget pressure.
Trump’s Policies Could Undermine the Fight to End America’s HIV Epidemic
The White House is asking Congress to sharply roll back federal spending on HIV prevention, a reversal from President Trump’s first term, when he championed investment to end the epidemic in America within a decade.
